Document is current
Any future updates will be listed below
-
Authors
Llovet, Josep M. https://orcid.org/0000-0003-0547-2667
- License Information
-
More Information
Article History
First Online: 27 January 2023
Competing interests
: J.M.L. has received research support from Bayer HealthCare Pharmaceuticals, Bristol Myers Squibb, Eisai and Ipsen, and consulting fees from AstraZeneca, Bayer HealthCare Pharmaceuticals, Bluejay Therapeutics, Boston Scientific, Bristol Myers Squibb, Captor Therapeutics, Eisai, Eli Lilly, Exelixis, Genentech, Glycotest, Ipsen, Merck, Mina Alpha, Omega Therapeutics and Roche.
